Hypertension Diagnostics, Inc. Newsroom


	Hypertension Diagnostics Announces FY 2004 Results ST. PAUL, MN – September 29, 2004 – Hypertension Diagnostics, Inc. (OTC: HDII.OB), today announced financial results for the fiscal year ended June 30, 2004. Revenue for the fiscal year ended June 30, 2004 totaled $1,074,515 compared to $775,336 in the prior year ended June 30, 2003, which represents a 39 per cent increase from the prior year. The Company incurred a net loss of $(1,839,949) for fiscal year 2004 or $(0.08) per share compared with a net loss of $(3,802,381) for fiscal year 2003 or $(0.45) per share. The Company reported a cash balance on June 30, 2004 of $1,378,293.
	Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company’s 2004 Annual Report on Form 10-KSB, and subsequent Quarterly Reports on Form 10-QSB, all of which were filed with the U.S. Securities and Exchange Commission, as well as others not now anticipated. FY 2004 Financial Summary View/Print file CVProfilor is a registered trademark of Hypertension Diagnostics, Inc. Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved. Website: www.HDII.com Contact: Mark Schwartz, CEO 651-687-9999 Return to the Main HDI Newsroom Back to Top

Copyright © 2009 Hypertension Diagnostics, Inc Last revised Wednesday February 11, 2009 HDI Legal Information